VoxNeuro secures Class II Medical Device designation

July 29, 2021

On July 28, 2021, VoxNeuro, The Forge alumnus, received Health Canada Class II Medical Device designation for its proprietary Cognitive Health Assessment Management Platform™ (CHAMP). VoxNeuro will begin rolling out the software as a medical device across its Canadian Test Centers. This news comes soon after VoxNeuro’s FDA registration for the distribution of CHAMP as a Class II Exempt Medical Device in the US market this past May.

VoxNeuro’s industry leading neurotechnology is elevating the evaluation of cognitive function. The CHAMP software works in tandem with VoxNeuro’s Cognitive Health Assessment™, a proprietary electroencephalography protocol. By analyzing electroencephalographic event-related potential (ERP) data gathered during the assessment, CHAMP provides rapid, objective and actionable scores of four key cognitive functions: memory, information processing, attention & concentration.

Read full ORIGINAL ARTICLE, financialpost.com, July 28, 2021.